These results also offer novel strategies for future treatment of cocaine addiction based on the removal of pathological A2AR-D2R-Sigma1R complexes with a strong brake on D2R Gi/o mediated signaling and a reduction of the D2R affinity (Borroto-Escuela et al., 2018d). The gene discussed is SIGMAR1; the disease is cocaine dependence.